Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Last day of the subscription period in Curasight's rights issue of shares

Curasight
Download the release

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE THIS PRESS RELEASE IS DISTRIBUTABLE WOULD BE ILLEGAL OR REQUIRE ADDITIONAL ACTIONS THAN SUCH ACTIONS RESULTING FROM DANISH LAW. SEE THE "IMPORTANT INFORMATION" SECTION AT THE END OF THIS PRESS RELEASE.

Friday, May 16, 2025, is the last day to subscribe to Curasight A/S ("Curasight" or the "Company" - TICKER: CURAS) ongoing rights issue of shares with preferential rights for existing shareholders (the "Rights Issue"). On 4 April 2025, the Board of Directors resolved on its intention to carry out the Rights Issue. The Extraordinary General Meeting held on 23 April 2025 authorized the Board to carry out the Rights Issue, and the Board subsequently resolved to carry out the Rights Issue on 24 April 2025. Please note that certain banks and custodians may have an earlier deadline for subscription in the Rights Issue than May 16, 2025. Shareholders are therefore advised to check with their bank or custodian to confirm whether an earlier deadline applies.

Summary of the Rights Issue

  • Each holder of existing shares registered with Euronext Securities as of the record date, 1 May 2025, have been allocated forty-three (43) subscription rights for each existing share held. Eighteen (18) subscription rights entitle the holder to subscribe for one (1) new share.
  • The subscription price is DKK 1.98 per share, and upon full subscription, Curasight will receive approximately DKK 100 million in gross proceeds through the Rights Issue before deduction of transaction costs
  • The rights issue is covered by subscription undertakings of approximately DKK 27.7 million by Curium, Pentwater, members of the Board of Directors & management and existing shareholders. In addition, the Rights issue is covered by guarantee commitments from a number of external investors, corresponding to a total of approximately DKK 19.3 million. In total, the Rights Issue is thus covered by subscription and guarantee commitments totaling approximately DKK 47 million, which corresponds to approximately 47% of the Rights Issue.

Disclosure document

No prospectus has been prepared in connection with the Rights Issue. The Company has prepared and published an information document (the "Information Document") in accordance with article 1.4 db) in Regulation (EU) 2024/2809 ("Listing Act"). Further information concerning the Rights Issue and the Company is provided in the Information Document, which has been prepared in accordance with Annex IX of the prospectus regulation (EU) 2017/1129 ("Prospectus Regulation"). The Information Document is available on the Company's website, www.curasight.com. This website also contain a link to the subscription form for subscription. 

Time plan for the Rights Issue

30 April 2025 - 14 May 2025 Trading in subscription rights
2 May 2025 - 16 May 2025 Subscription period
21 May 2025 Estimated publication of the outcome of the Rights Issue

Advisors

Sedermera Corporate Finance AB acts as Sole Global Coordinator and bookrunner in connection with the Rights Issue. DLA Piper is the Company's legal advisor. Danske Bank A/S is the settlement agent.

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.